Results 81 to 90 of about 8,054 (175)

Transcatheter aortic valve implantation: predictors of procedural success—the Siegburg-Bern experience [PDF]

, 2017
Aims The purpose of the present analysis was to identify predictors of procedural success of percutaneous transcatheter aortic valve implantation (TAVI). Methods and results We prospectively assessed in-hospital outcome of patients undergoing TAVI at two
Buellesfeld, Lutz, Gerckens, Ulrich, Grube, Eberhard, Hellige, Gerrit, Latsios, Georg, Mueller, Ralf, Sauren, Barthel, Wenaweser, Peter, Windecker, Stephan, Zickmann, Bernfried   +9 more
core  

In Vitro Calcification of Bioprosthetic Heart Valves: Method Validation by Comparative Heart Valve Calcification Testing

Artificial Organs, EarlyView.
We have developed a unique method for pre‐clinical heart valve prostheses evaluation of calcification propensity. Results from the test can directly be translated into improvements of prostheses design, materials, and anti‐calcification treatments, and therefore have a significant impact on heart valve prostheses quality and patient care in the future.
Nicole Kiesendahl, Christoph Schmitz, Lars Peters, Marek Weiler, Thomas Schmitz‐Rode, Ulrich Steinseifer, Johanna C. Clauser   +6 more
wiley   +1 more source

Triple Björk-Shiley valve: More than 30 years of asymptomatic functioning: To the memory of late academic Prof. Isidor Papo and the 45th anniversary of the first valve implantation in Yugoslavia [PDF]

, 2010
Introduction. The Björk-Shiley Delrin (BSD) tilting disc heart valve was first clinically used in 1969. A triple BSD valve replacement has not been quite common, because of high postoperative risk and complications, but there have been several cases with
Krotin Mirjana, Milenković-Krotin Jelisaveta, Zdravković Marija   +2 more
core   +1 more source

German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation—Outcomes of the MYLAND (MYvaL germAN stuDy) Study

Journal of Clinical Medicine
Background: The primary objective of this study was to evaluate the initial experience in Germany with the Meril Myval™ (MM) transcatheter heart valve (THV) system for the treatment of severe symptomatic aortic valve stenosis. The MM THV is a novel balloon-expandable valve with an expanded sizing matrix.
Timm Ubben, Eike Tigges, Won-Keun Kim, Andreas Holzamer, Ingo Breitenbach, Ralf Sodian, Jürgen Rothe, Willibald Hochholzer, Samer Hakmi, Franz-Josef Neumann   +9 more
openaire   +3 more sources

Trial‐Based Hemolysis Modeling to Investigate Operating Modes of Continuous‐Flow LVADs

Artificial Organs, EarlyView.
This work presents a methodology for determining online‐capable hemolysis models for continuous‐flow LVADs, derived from in vitro trials. The models are based on fitting a modified power law and applying the Lagrangian approach. They assist clinicians in selecting treatment strategies that minimize hemolysis, as demonstrated with the Sputnik1 LVAD ...
Patrick Borchers, Steffen Leonhardt, Marian Walter   +2 more
wiley   +1 more source

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Bleiziffer, S, Bosmans, J, Brecker, S, Busca, R, Eaton, J, Gerckens, UJ, Linke, A, Mealing, S, Moat, N, Padhiar, A, Piazza, N, Sculpher, M, Tamburino, C, Wenaweser, P   +13 more
core   +1 more source

Inflammatory Cytokines as Early Predictors of Weaning Failure From Extracorporeal Life Support

Artificial Organs, EarlyView.
Levels of IL‐8 and IL‐6 and their dynamics are reliable early predictors of ECLS weaning failure. ABSTRACT Background Weaning from extracorporeal life support (ECLS) in patients with refractory shock still remains a complex decision. Despite considerable advances in ECLS management, reliable biomarkers to predict weaning success are still not available.
Kostiantyn Kozakov, Alois Philipp, Maik Foltan, Anton Heller, Dzmitry Turtsevich, Christian Schach, Peter‐Paul Ellmauer, Walter Petermichl, Bernhard Flörchinger, Christof Schmid, Simon Schopka, Zdenek Provaznik   +11 more
wiley   +1 more source

Surgical Bailout Therapy after Implantation of a Medtronic CoreValve Bioprosthesis

Case Reports in Cardiology, 2012
Moderate-to-severe paraprosthesic leak causing hemodynamic deterioration and left ventricular remodeling can occur after transcatheter aortic valve implantation (TAVI).
Rita Calé, José Neves, Rui Teles, João Brito, Miguel Abecasis, Manuel Almeida, Tiago Nolasco, Miguel Mendes   +7 more
doaj   +1 more source

Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design [PDF]

, 2017
OBJECTIVES The aim was to investigate the safety and feasibility of the redesigned Engager™ transcatheter aortic valve implantation (TAVI) system.
Bleiziffer, Sabine, Corti, Roberto, Falk, Volkmar, Grünenfelder, Jürg, Lange, Rüdiger, Linke, Axel, Rastan, Ardawan J., Sündermann, Simon H.   +7 more
core   +1 more source

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source